positions available now

Category Archives: Life Sciences Industry

Relating to the Life Sciences Industry in general

Commercial Eyes Recruiting: Research Associate, Market Access

Apply your research and healthcare skills to support our growing market access team.   The role… This role is part of the Market Access team and will work closely with consultants to deliver expert consulting services to clients in the … Continue reading

Posted in Commercial Eyes, Life Sciences Industry, Market Access, Recruiting | Tagged , , , | Comments Off on Commercial Eyes Recruiting: Research Associate, Market Access

PHARMAC issues a call for funding applications for medicines for rare disorders

Applications will be accepted until 5pm on the 5th of August 2019 and will be considered by the Rare Disorders Subcommittee at their meeting scheduled for the 24th of September 2019.   Eligibility criteria: The medicine must have been approved … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on PHARMAC issues a call for funding applications for medicines for rare disorders

Are you ready for the mandatory transition to eCTD for prescription medicines?

In October 2018 the TGA announced the long-awaited timelines for transition to eCTD. A staged implementation has been proposed for prescription medicines to reflect the current industry uptake of the eCTD format. The transition begins with new chemical entity, new … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , , , | Comments Off on Are you ready for the mandatory transition to eCTD for prescription medicines?

November 2018 PBAC Meeting Agenda

The November 2018 PBAC Meeting is scheduled to conclude today. Here, the Commercial Eyes Market Access team provides an analysis of the meeting agenda, including Sponsors with multiple submissions and the nature of requested listings by type.     The … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , | Comments Off on November 2018 PBAC Meeting Agenda

PBAC Meeting Outcomes – July 2018

The July 2018 PBAC Meeting Outcomes were published on 17th August 2018. With 64 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including additional analysis conducted on biosimilar and oncology submissions.   … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , | Comments Off on PBAC Meeting Outcomes – July 2018

Public Submissions to the August 2018 PBAC Special Meeting – Part 2

In the second part of this two-part series (Read Part 1 about here) we bring you further insight into opinions from the public submissions to the August 2018 PBAC Special Meeting. Opinions from the Public Submissions Outcomes of the PBAC’s … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , , | Comments Off on Public Submissions to the August 2018 PBAC Special Meeting – Part 2

Sponsors struggle with Ministerial discretion

The 2017 Medicines Australia Strategic Agreement with the Australian Government extended the existing five-year anniversary statutory price reduction (SPR) of 5% for F1 medicines and introduced new SPRs for drugs that have been listed for ten years and fifteen years … Continue reading

Posted in Life Sciences Industry, Market Access, PBS | Tagged , , , | Comments Off on Sponsors struggle with Ministerial discretion

The long road to PBS listing for Orkambi

Orkambi (lumacaftor and ivacaftor), a treatment for cystic fibrosis (CF), will go before the PBAC for a fourth time at the upcoming July 2018 PBAC meeting. So far, the road to reimbursement has been filled with multiple rejections, a strong … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , | Comments Off on The long road to PBS listing for Orkambi

PBAC Meeting Agenda – July 2018

The July 2018 PBAC Meeting is scheduled from 4 to 6 Jul 2018. Here, the Commercial Eyes Market Access team provides an overview of the meeting agenda, including submissions relating to biosimilars lodged for this meeting.     The Commercial … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , , , | Comments Off on PBAC Meeting Agenda – July 2018

PBAC Meeting Outcomes – March 2018

The March 2018 PBAC Meeting Outcomes were published on 20th April 2018. With 71 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including an additional analysis conducted on oncology submissions which have … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , , | Comments Off on PBAC Meeting Outcomes – March 2018
Copyright © 2014 Commercial Eyes